REGISTERED CHARITY NUMBER: 1154856 LEUKA REPORT OF THE TRUSTEES AND AUDITED FINANCIAL STATEMENTS FOR THE 9 MONTHS ENDED 31ST DECEMBER
CONTENTS OF THE FINANCIAL STATEMENTS FOR THE 9 MONTHS ENDED 31ST DECEMBER Page Report of the Trustees 1 to5 Report of the Independent Auditors Statement of Financial Activities Balance Sheet Notes to the Financial Statements 9 to 14
REPORT OF THE TRUSTEES FOR THE 9 MONTHS ENDED 31ST DECEMBER The trustees present their report with the financial statements of the charity for the period ended 31st December. The trustees have adopted the provisions of the Statement of Recommended Practice (SORP) 'Accounting and Reporting by Charities' issued in March 2005. REFERENCE AND ADMINISTRATIVE DETAILS Registered Charity number 1154856 Registered Office Catherine House 76 Gloucester Place London W1U 6HJ Trustees Chdis Corbin (Chairman) Professor Edward Gordon-Smith (appointed 9 October ) David Hawkins FCA (until 16 December ) David Lewis FRICS John Macey (appointed 9 October ) Auditors Price & Company Chartered Accountants and Statutory Auditor 30/32 Gildredge Road Eastbourne East Sussex BN21 4SH Investment managers J M Finn & Co, 4 Coleman Street, London, EC2R STA. Investec Wealth and Investment Ltd, 2 Gresham Street, London, EC2V 7QP. Bankers HSBC Bank Pic., 4 Robertson Street, Hastings, East Sussex, TN34 1HW. Rothschild Bank International Ltd, St. Julian's Court, St. Peter Port, Guernsey, GY1 3BP. STRUCTURE, GOVERNANCE AND MANAGEMENT Structure and Governance The charity is constituted as a Chaditable Incorporated Organisation and is governed by a constitution dated 3 December 2013 and was registered with the Charity Commission as a charity on that date. The Board of Trustees meets at least three times a year and delegates the day-to-day management to a Chief Executive who oversees aspects of governance, fund-raising and charitable activity. Recruitment and appointment of new trustees Currently, new trustees are invited by agreement of the existing trustees having due regard to the skills, knowledge and experience required for the effective administration of the charity. Trustees are appointed for a term of three years and may be reappointed.
REPORT OF THE TRUSTEES FOR THE 9 MONTHS ENDED 31ST DECEMBER STRUCTURE, GOVERNANCE AND MANAGEMENT (continued) Risk management The trustees actively review the major strategic, business and operational risks which the charity faces and believe that maintaining adequate levels of reserves, combined with an annual review of controls over key financial systems, will provide sufficient resources in the event of adverse conditions. The trustees have also examined other operational and business risks faced by the charity and confirm that they have established systems to manage the significant risks. OBJECTIVES AND ACTIVITIES Objectives and aims The objective of Leuka is to relieve sickness and preserve and protect health, in particular, by promoting research into leukaemia and/or related disorders; and providing support directly or indirectly to people affected by leukaemia and or related disorders including the maintenance of specialist treatment units. In March the board of trustees approved a resolution to accept the transfer of the assets, liabilities and undertakings of the charitable trust Leuka (charity number 286231 now wound up), together with its subsidiary company Leuka 2000 (Appeals) Limited (now dormant). The transfer took effect at midnight on 31" March and the total funds transferred amounted to f3,785,255. The charity has undertaken to carry on the work of Leuka (the charitable trust) and the funds transferred will be applied to the charitable objectives; any restrictions on the application of those funds will be maintained. Principal Activity Leuka's long-term vision is a future free from cancer. Our mission is to improve the lives of patients with leukaemia, other blood cancers and related disorders. Leuka's niche is funding leukaemia related research by supporting specialist research and clinical staff, as well as supporting the provision of high quality facilities and cutting edge technology needed to undertake relevant research. Leuka's general approach to fundraising is to solicit unrestricted funding to enable maximum flexibility with regard to how funds are applied in line with our overall charitable objects. Given Leuka's size, our aim is to complement and "add value" to work being undertaken by other larger charities and major research bodies. Leuka strives to work in partnership with other agencies where this will result in scientific advantage and the leveraging of more resources for leukaemia related research and care. Leuka supports innovation and aims to augment capacity and capability to enhance patients' wellbeing rather than to fund core day-to-day NHS services. Leuka's funds are not used to substitute for work/services that should be properly funded by public funds. Instead, the charity supports new developments and the provision of additional facilities and services that improve research, clinical care and the patient experience. One of the proudest achievements of the charitable trust Leuka, was funding the building of the Catherine Lewis Centre in West London, which opened in 2002 as a flagship haematology centre. Imperial College Healthcare NHS Trust runs the Catherine Lewis Centre and similar Centres of Excellence now exist elsewhere around the UK. Meanwhile, Leuka continues to support world-class research delivered by top scientists and doctors from within environments and institutions of the highest quality around the UK and beyond. Priorities Leuka's focus is leukaemia related research. Supporting both research and specialist clinical management lies at the heart of the charity's work. During the calendar year, due to a reorganisation to make the charity more efficient and effective, we distributed a modest amount of funds relative to our income and reserves. Over the next 3 years Leuka aims to address this by:
REPORT OF THE TRUSTEES FOR THE 9 MONTHS ENDED 31ST DECEMBER ~ Developing our programme of charitable activity. ~ Using this increase in charitable activity to leverage an increase in income by investing in additional marketing and fundraising activity. From 2015 we will begin supporting a more varied programme of charitable activity along the lines set out below. The precise details of our grants portfolio will evolve in step with further needs assessment and consultation with the field. Charitable activity - plans In we put in place a more rigorous, transparent system of applying for Leuka funds, with the establishment of an independent scientific panel and the introduction of peer review to guide trustee decisionmaking. In 2015 we will launch a new grants programme in memory of Leuka's founding chairman Professor John Goldman, who was a renowned haematologist and a pioneer in the treatment of leukaemia. The John Goldman Fellowships for Future Science initiative will aim to fund at least five such fellowships each year for the next three years. We will also aim to enhance our other grants programmes to support those with a passion for science and a talent for translating scientific advances into clinical practice. In addition, given Leuka's reserves we are considering supporting at least one more significant initiative over the next three-year period. This is likely to be a research or clinical project in partnership with another leading institution in the field of leukaemia related research. In selecting collaborators Leuka trustees will be guided by our scientific advisors and independent experts. We are also exploring innovative ways to new promote awareness of Leuka's cause and to encourage and reward scientific and clinical excellence Where the charity holds or receives funds restricted to the upkeep of the Catherine Lewis Centre in West London, these will be utilised to help maintain and equip the Centre in keeping with the wishes of the original benefactors. As far as possible Leuka will encourage Imperial College Healthcare NHS Trust who are responsible for the Centre to fulfill its obligation to do likewise. Resource mobilisation Our goal over the next three years is to fund the priorities outlined above and to develop a longer-term and sustainable programme of charitable activity. This will require Leuka to achieve increased income targets during this period and beyond. To do this we must retain our focus on fundraising, specifically in those areas of activity that have in the past produced the most income for the least expenditure. At the same time Leuka aims to diversify its income streams to build on those aspects of its current fundraising activity that are working well, whilst at the same time investing in new initiatives, some of which may not see an immediate return in the first 12-18 months. Looking forward we need to find ways of developing and sustaining new income streams from across a wider regional, national and global constituency than hitherto. Our resource mobilisation programme will therefore be developed accordingly.
REPORT OF THE TRUSTEES FOR THE 9 MONTHS ENDED 31ST DECEMBER Improving Governance In Leuka introduced more rigour into its grant making through, where appropriate, a transparent open application process and peer-review. From 2015 the charity will implement clearer guidelines and formal reporting systems, which allow for greater synergy between the fundraising effort and the funded programme, along with better accountability to donors. By the end of Leuka had put in place an Independent Scientific Committee, made up of world-class experts whose role is to independently access applications for research funding, as appropriate. From 2015 only research and initiatives that have been independently assessed as worthy of funding and recommended to Leuka trustees will be considered for financial support. This approach will ensure better governance and accountability. Furthermore, Leuka's strategy to invite applications for research funds from across UK academic or clinical institutions and to introduce a peer-review process will make its funds eligible to attract matched funds from the Charity Research Support Fund meaning Leuka funds will be able to make more impact. Grants made following open competition mean the recipient institutions will also be eligible for the Charity Research Support Fund (universities - HEFCE) top-up subsidy. In 2015 Leuka will look at applying for membership of the Association of Medical Research Charities (AMRC). Membership criteria require the charity to adopt a research strategy and establishment an Independent Scientific Panel to guide its decision-making. FINANCIAL REVIEW Reserves policy The trustees ensure that reserves are maintained at a level that enables the charity to meet its ongoing grant making commitments and its operating costs as well as managing financial risk and fluctuating income levels as its seeks to develop new income streams on a long term basis. A designated fund for grant making has been created and the trustees have transferred sufficient funds from the general reserves to meet the anticipated grant making programme for the coming financial year. Investment policy and objectives The trustees have adopted a cautious and prudent approach to investment of its funds and in order to ensure appropriately diversified investments have agreed for the charity's funds be split between (1) short and medium term bank money market deposits and (2) a portfolio of investments managed by two firms of stockbrokers. This split of resources is designed to balance potential returns with appropriate risk as well as ensuring sufficient liquidity to meet cash flow requirements. The charity has a policy of not investing in tobacco companies. Financial position Due to the change in legal structure, these accounts cover the 9 month period ended 31 December and show total incoming resources of 5395,492 with total resources expended of E511,942. After taking other recognised gains/losses into consideration, the net movement in funds for the period was net outgoing resources of 674, 331. The total funds transferred from Leuka, the charitable trust, amounted to E3,785,255 and the total funds held at the end of the period therefore amounted to F3,710,924. PUBLIC BENEFIT The trustees have complied with their duty in Section 4 of the Charities Act 2006 to have due regard to guidelines issued by the Charity Commission. The charity funds research into the causes and treatment of leukaemia and considers that its work is of benefit to the public.
REPORT OF THE TRUSTEES FOR THE 9 MONTHS ENDED 31ST DECEMBER STATEMENT OF TRUSTEES RESPONSIBILITIES The trustees are responsible for preparing the Report of the Trustees and the financial statements in accordance with applicable law and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice). The law applicable to charities in England and Wales, the Charities Act 2011, Charity (Accounts and Reports) Regulations 2008 and the provisions of the trust deed requires the trustees to prepare financial statements for each financial year which give a true and fair view of the state of affairs of the charity and of the incoming resources and application of resources, including the income and expenditure, of the charity for that period. In preparing those financial statements, the trustees are required to select suitable accounting policies and then apply them consistently; observe the methods and principles in the Charity SORP; make judgements and estimates that are reasonable and prudent; prepare the financial statements on the going concern basis unless it is inappropriate to presume that the charity will continue in business. The trustees are responsible for keeping proper accounting records which disclose with reasonable accuracy at any time the financial position of the charity and to enable them to ensure that the financial statements comply with the Charities Act 2011, the Charity (Accounts and Reports) Regulations 2008 and the provisions of the trust deed. They are also responsible for safeguarding the assets of the charity and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities. ON BEHALF OF THE BOARD Chris Corbin, Chairman D.t'i...L&:.4:,~.i~~
REPORT OF THE INDEPENDENT LEUKA AUDITORS TO THE TRUSTEES OF We have audited the financial statements of Leuka for the period ended 31st December on pages seven to fourteen. The financial reporting framework that has been applied in their preparation is applicable law and the Financial Reporting Standard for Smaller Entities (effective April 2008) (United Kingdom Generally Accepted Accounting Practice applicable to Smaller Entities). This report is made solely to the charity's trustees, as a body, in accordance with Section 144 of the Charities Act 2011 and regulations made under Section 154 of that Act. Our audit work has been undertaken so that we might state to the charity's trustees those matters we are required to state to them in an auditors' report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the charity and the charity's trustees as a body, for our audit work, for this report, or for the opinions we have formed. Respective responsibilities of trustees and auditors As explained more fully in the Statement of Trustees' Responsibilities, the trustees are responsible for the preparation of the financial statements that give a true and fair view. We have been appointed as auditors under Section 144 of the Charities Act 2011 and report in accordance with regulations made under Section 154 of that Act. Our responsibility is to audit and express an opinion on the financial statements in accordance with applicable law and International Standards on Auditing (UK and Ireland). Those standards require us to comply with the Auditing Practices Board's Ethical Standards for Auditors. Scope of the audit of the financial statements An audit involves obtaining evidence about the amounts and disclosures in the financial statements sufficient to give reasonable assurance that the financial statements are free from material misstatement, whether caused by fraud or error. This includes an assessment of: whether the accounting policies are appropriate to the charity's circumstances and have been consistently applied and adequately disclosed; the reasonableness of significant accounting estimates made by the trustees; and the overall presentation of the financial statements. In addition, we read all the financial and non-financial information in the Report of the Trustees to identify material inconsistencies with the audited financial statements. If we become aware of any apparent material misstatements or inconsistencies we consider the implications for our report. Opinion on financial statements In our opinion the financial statements: give a true and fair view of the state of the charity's affairs as at 31st December and of its incoming resources and application of resources for the period then ended; have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and have been prepared in accordance with the requirements of the Charities Act 2011. Matters on which we are required to report by exception We have nothing to report in respect of the following matters where the Charities Act 2011 requires us to report to you if, in our opinion: the information given in the Report of the Trustees is inconsistent financial statements; or in any material respect with the sufficient accounting records have not been kept; or the financial statements are not in agreement with the accounting records and returns; or we have not received all the information and explanations we require for our audit. Price & Company Chartered Accountants and Statutory Auditor 30/32 Gildredge Road Eastbourne East Sussex Wjfi(20(5 Price & Company are eligible to act as an auditor in terms of section 1212 of the Companies Act 2006 6
STATEMENT OF FINANCIAL ACTIVITIES FOR THE 9 MONTHS ENDED 31ST DECEMBER INCOMING RESOURCES Notes Unrestricted funds F Restricted funds 6 Total funds 6 Incoming resources from generated funds: Voluntary income Investment income 129,444 67,569 198,479 327,923 67,569 Total incoming resources 197,013 198,479 395,492 RESOURCES EXPENDED Costs of generating funds: Fundraising and Marketing Investment management fees Charitable activities: Research Grants Patient Benefit Activities Governance costs 7,10 7,10 7 79,373 12,240 127,275 41,749 1,088 32,088 218,129 80,461 12,240 159,363 218,129 41,749 Total resources expended 260,637 251,305 511,942 NET INCOMING/(OUTGOING) RESOURCES Other recognised gains/(losses) Gains/(losses) on investment assets 42,119 42,119 Net movement in funds 15 (21,505) (52,826) (74,331) Total funds brought forward Total funds transferred from charitable trust 15 3,365,151 420, 104 3,785,255 TOTAL FUNDS CARRIED FORWARD 3,343,646 367,278 3,710,924 The notes to the accounts form part of these financial statements
BALANCE SHEET AT 31ST DECEMBER Notes F FIXED ASSETS Investments 2,078,485 CURRENT ASSETS Debtors: amounts falling due within one year Cash at Bank 12 11,246 1,752,682 CURRENT LIABILITIES Creditors: amounts falling due within one year NET CURRENT ASSETS 1,763,927 13 131,488 1,632,439 TOTAL ASSETS LESS CURRENT LIABILITIES 3,710,924 FUNDS Restricted Funds Designated Funds Unrestricted Funds 15 367,278 1,035,203 2,308,443 3,710,924 The financial statements were approved by the Board of Trustees on... behalf by:... and were signed on its Chris Corbin Chairman David Lewis Trustee The notes to the accounts form part of these financial statements
NOTES TO THE FINANCIAL STATEMENTS FOR THE PERIOD ENDED 31ST DECEMBER 1. ACCOUNTING POLICIES (a) Basis of preparation The financial statements have been prepared under the historical cost convention modified to include the revaluation of investments and in accordance with the Charities Act 2011,applicable accounting standards and the Statement of Recommended Practice "Accounting and Reporting by Charities" (SORP) 2005. The charity has taken advantage of the exemptions provided under the SORP 2005 and has not prepared a cash flow statement for the period on the grounds that it qualifies as a small charity. (b) Incoming resources All incoming resources are included on the Statement of Financial Activities when the charity has entitlement, there is certainty of receipt and the amount is measurable. For donations and gifts this is when they are received. Gift Aid is recognised on a receivable basis as part of the income to which it relates. Grants are recognised in full in the year in which they are receivable except in situations where they are related to performance in which case they are accrued as the charity earns the right through performance. Fund raising income is accounted for gross. Interest is recorded when it is received. Dividends are accounted for when due, and tax recoverable on such income is accounted for on the basis of the repayment due in the fiscal year ending in that accounting year. Realised gains or losses are recognised when investments are sold. Unrealised gains or losses are accounted for on revaluation of investments at the period end. (c) Resources expended Expenditure is accounted for on an accruals basis and liabilities are recognised as expenditure when there is a legal obligation committing the charity to the expenditure, it is probable that settlement will be made and the obligation can be measured. Non recoverable VAT is included against the expenditure heading to which it relates. Where costs cannot be directly attributed to an activity including support and office costs they have been allocated to activity cost categories on a basis consistent with the use of the resource estimated time spent or resource used. Grants payable are payments made to third parties in furtherance of the charity's objectives. Unconditional grant offers are accrued once the recipient has been advised of the grant award. Where grant awards are subject to performance conditions that are outside of the control of the charity these are accrued when the recipients has been notified of the grant award. Multi-year grants are recognised at their present value where payments are due over more than one year from the date of the award, there are no unfulfilled conditions which are within the control of the charity and the effect of discounting is material. (d) Taxation As a registered charity income and gains are exempt from Corporation Tax to the extent that they are applied to the charitable objectives. (e) Fund accounting Unrestricted funds can be used in accordance with the charitable objectives at the discretion of the trustees. Designated Funds are unrestricted funds which have been designated for a specific purpose by the trustees. Restricted funds can only be used for particular restricted purposes within the objects of the charity. Restrictions arise when specified by the donor or when funds are raised for particular restricted purposes. Further explanation of the nature and purpose of each fund is included in the notes to the financial statements.
NOTES TO THE FINANCIAL STATEMENTS - CONTINUED FOR THE PERIOD ENDED 31ST DECEMBER 1. ACCOUNTING POLICIES - CONTINUED (f) Investments The investments are re-valued at market value at 31 December which gives rise to unrealised gains/losses at the end of the financial period which are reflected in the SOFA. Realised gains/losses are calculated as the difference between the sales proceeds and the opening carrying value or the purchase price if acquired during the financial period. Partial disposals are accounted for using the average value. (g) Pensions Pension contributions payable under a defined contribution scheme are charged to the SOFA in the accounting period to which they relate. (h) Group financial statements Consolidated financial statements have not been prepared as the subsidiary company; Leuka 2000 (Appeals) Limited, has been dormant for the entire period covered by these financial statements. 2. RELATED PARTY TRANSACTIONS During the period, accountancy services were provided by Gibbons Mannington Phipps, a firm in which DSS Hawkins who was a trustee until 16 December and who is a Director of the subsidiary company, is a partner. The fees paid during the period inclusive of non recoverable Vat amounted to E2,004. 3.TRUSTEE REMUNERATION AND BENEFITS The trustees all give their time and expertise freely and do not receive any form of remuneration or benefit in cash or in kind. They are entitled to claim reasonable expenses for travel and other costs associated with their service as trustees. No trustee expenses were claimed or paid in the period ending 31 December. 4. SUBSIDIARY UNDERTAKING The charity has a wholly owned subsidiary, Leuka 2000 (Appeals) Limited, which has not traded since 31 December. Two of the Trustees of the charity, Chris Corbin and David Lewis, are also Directors of the company as is David Hawkins who was a trustee until 16 December. None of the Directors of the company receive any remuneration from the company. 5.VOLUNTARY INCOME Donations Including Gift Aid Grants 5 201,923 126,000 327, 923 6. INVESTMENT INCOME Investment Income Bank Interest E 56,275 11,294 67, 569 10
NOTES TO THE FINANCIAL STATEMENTS - CONTINUED FOR THE PERIOD ENDED 31ST DECEMBER 7. RESOURCES EXPENDED Costs of Generating funds Fundraising and marketing Investment Management Costs Grants Direct Staff Allocated Costs Support Costs 11,718 60,631 8, 112 12,240 f 80,461 12,240 Charitable Activities Research Grants 128,806 64 23, 394 7,099 Patient Benefit 213,763 10 3,342 1,014 Governance Costs 14,990 22, 702 4,057 159,363 218,129 41,749 Total Resources Expended 342, 569 39,022 110,069 20,282 511,942 Direct costs are those costs associated with providing the activity such as materials, advertising, postage and stationery, venue and travel costs. Support Costs includes office and other costs which cannot be directly attributed to any one activity. Staff and Support Costs are allocated on the basis of the estimated time spent on each activity and the estimated proportion of the resources used. Direct Costs attributed to Governance Costs includes auditor's remuneration, legal and professional fees and the costs associated with preparing trustee packs and arranging trustee meetings. Research Grants are grants awarded towards the costs of scientific research. Patient Benefit grants include grants awarded for the maintenance of specialist units, pieces of equipment for use in patient care and projects intended to share learning and improve clinical practice. 8. NET OUTGOING RESOURCES Net outgoing resources are stated after charging auditor's remuneration of 61,920. 9. STAFF COSTS AND NUMBERS Wages and Salaries Employers National Insurance Pension Costs 105,205 3,597 9,408 118,210 No employee was in receipt of salary and benefits in excess of f60,000. The average number of full time equivalent employees during the year was 3.
NOTES TO THE FINANCIAL STATEMENTS - CONTINUED FOR THE PERIOD ENDED 31ST DECEMBER 10. GRANTS PAID IN THE PERIOD SHOWN BY INSTITUTION Research Grants: Imperial College London 8 128,806 Patient Benefit: Imperial College London NHS Healthcare Trust Imperial College London University of Liverpool 8 11,800 138,963 63,000 213,763 11. FIXED ASSET INVESTMENTS MARKET VALUE Transferred at 1 April Acquisitions Disposals Net gains/(losses) on revaluation At 31 December Cash held as part of Investment Total Portfolio 2,001,208 219,070 (211,161) 38,711 2, 047,828 30,657 2,078,485 Investments comprise the following: Investment in subsidiary company Fixed Interest UK Bonds Non UK Fixed Interest Bonds UK Equities and Funds Non UK Equities and Funds Other funds including cash Total 10 291,532 1,071,406 431,527 284, 010 2, 078,485 12. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR Prepayments Gift Aid and accrued income 9,046 2,200 11,246 13.CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR Creditors Accruals 8 8,435 123,053 131,488 12
NOTES TO THE FINANCIAL STATEMENTS - CONTINUED FOR THE PERIOD ENDED 31ST DECEMBER 14. ANALYSIS OF NET ASSETS BETWEEN FUNDS Investments Current Assets Current Liabilities Unrestricted Funds 6 2, 078,485 1,311,211 46,050 3,343,646 Restricted Funds 6 452, 716 85,438 367,278 Total Funds 6 2, 078,485 1,763,927 ~131,488 3,710,924 15. MOVEMENT IN FUNDS Restricted Funds: Catherine Lewis Centre- Maintenance CML Alliance Dept of Haematology- Hammersmith Hospital Designated Funds: Catherine Lewis Centre- Maintenance Planned Grant Making Unrestricted Funds General Fund Funds from Net movement Transfers At 31.12.14 charitable in funds between funds trust 8 E 6 49,821 369,208 (112,417) 49,821 256,791 1,075 59,591 60,666 420, 104 52,826 367,278 35,203 35,203 700,397 127,275 426, 878 1,000, 000 735,600 127,275 426, 878 1,035,203 2,629, 551 105,770 426, 878 2, 308,443 TOTAL FUNDS 3,785, 255 74,331 3,710,924 13
NOTES TO THE FINANCIAL STATEMENTS - CONTINUED FOR THE PERIOD ENDED 31ST DECEMBER 15. MOVEMENT IN FUNDS - continued Restricted Funds: Catherine Lewis Centre- Maintenance CML Alliance Dept of Haematology- Hammersmith Hospital CML Registry Incoming Resources 8 Resources Expended (112,417) 72,479 (12,888) 126,000 (126,000) Gains/Losses Net Movement in Funds 8 8 6 (112,417) 59,591 Designated Funds: Catherine Lewis Centre- Maintenance Planned Grant Making (127,275) (127,275) Unrestricted General Fund Funds 197,013 (133,362) 42, 119 105,770 TOTAL 395,492 511,942 42, 119 74 331 Purpose of Restricted Funds: Catherine Lewis Centre Maintenance: The Catherine Lewis Centre was built using funds raised by the charitable trust Leuka. This fund was established to contribute towards the upkeep and maintenance of the centre. CML Alliance: This fund was established to create a network to share best practice in the care of patients with Chronic Myeloid Leukaemia. Dept of Haematology Hammersmith Hospital: Funds received where the donor or fundraiser has stipulated that the funds are to be used in support of the Department of Haematology at the Hammersmith Hospital. CML Registry: This fund was established to create a comprehensive database of patients diagnosed with and treated for Chronic Myeloid Leukaemia in a partnership between the University of Liverpool and Imperial College London. 14